These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

378 related items for PubMed ID: 3976309

  • 1. [Results of immunosuppressive therapy of chronic glomerulonephritis in 400 patients].
    Müller V, Natusch R, Göbel U, Laske HR, Sperschneider H, Pap I, Sinn W, Koall W, Achenbach H, Tredt HJ.
    Z Urol Nephrol; 1985 Jan; 78(1):39-55. PubMed ID: 3976309
    [Abstract] [Full Text] [Related]

  • 2. Immunosuppressive treatment of the glomerulonephritis of systemic lupus.
    Faedda R, Palomba D, Satta A, Pirisi M, Tanda F, Bartoli E.
    Clin Nephrol; 1995 Dec; 44(6):367-75. PubMed ID: 8719548
    [Abstract] [Full Text] [Related]

  • 3. [Comparison of two cyclophosphamide treatment regimens in nephrotic patients with chronic glomerulonephritis].
    Krasnova TN, Shilov EM, Tareeva IE, Gordovskaia NB, Lavrova ON, Miroshnichenko NG, Troepol'skaia OV, Ivanova LV, Ivanov AA.
    Ter Arkh; 1998 Dec; 70(6):14-7. PubMed ID: 9695216
    [Abstract] [Full Text] [Related]

  • 4. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate.
    du Buf-Vereijken PW, Branten AJ, Wetzels JF, Membranous Nephropathy Study Group.
    Nephrol Dial Transplant; 2004 May; 19(5):1142-8. PubMed ID: 14993502
    [Abstract] [Full Text] [Related]

  • 5. [Results of the treatment of mesangiocapillary glomerulonephritis].
    Rodríguez JA, Olmos A, Ferrer E, Mauri JM, Capdevilla L, Codina S, Alsina J, Camps J, Piera L.
    Rev Clin Esp; 1975 Dec 15; 139(5):415-22. PubMed ID: 1215585
    [No Abstract] [Full Text] [Related]

  • 6. [Monitoring of the clinical and morphological course of glomerulonephritis].
    Pap I, Kemnitz P, Willgeroth Ch.
    Z Urol Nephrol; 1978 Jun 15; 71(6):369-74. PubMed ID: 685514
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity.
    du Buf-Vereijken PW, Wetzels JF.
    Nephrol Dial Transplant; 2004 Aug 15; 19(8):2036-43. PubMed ID: 15187191
    [Abstract] [Full Text] [Related]

  • 8. Effect of combined immunosuppressive anticoagulant and antiplatelet therapy of the course of chronic mesangial-proliferative glomerulonephritis.
    Matousovic K, Matl I, Zabka J, Zástava V, Rossmann P, Prát V.
    Czech Med; 1985 Aug 15; 8(3):151-7. PubMed ID: 3932033
    [Abstract] [Full Text] [Related]

  • 9. [Diagnosis and therapy of chronic glomerulonephritis in long-term follow-up].
    Sinn W.
    Z Urol Nephrol; 1986 Feb 15; 79(2):59-66. PubMed ID: 3705778
    [Abstract] [Full Text] [Related]

  • 10. Immunosuppressive treatment of the nephrotic syndrome due to mesangial lesions.
    Faedda R, Pirisi M, Satta A, Tanda F, Bartoli E.
    Clin Nephrol; 1996 Oct 15; 46(4):237-44. PubMed ID: 8905208
    [Abstract] [Full Text] [Related]

  • 11. [Sandimmun in the treatment of chronic glomerulonephritis with the nephrotic syndrome].
    Krasnova TN, Tareeva IE, Shilov EM, Mukhin NA, Miroshnichenko NG.
    Ter Arkh; 1997 Oct 15; 69(6):21-3. PubMed ID: 9297266
    [Abstract] [Full Text] [Related]

  • 12. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
    Branten AJ, Wetzels JF.
    Clin Nephrol; 2001 Jul 15; 56(1):1-9. PubMed ID: 11499653
    [Abstract] [Full Text] [Related]

  • 13. Conversion to sirolimus from cyclosporine may induce nephrotic proteinuria and progressive deterioration of renal function in chronic allograft nephropathy patients.
    Boratyńska M, Banasik M, Watorek E, Falkiewicz K, Patrzałek D, Szyber P, Klinger M.
    Transplant Proc; 2006 Jul 15; 38(1):101-4. PubMed ID: 16504675
    [Abstract] [Full Text] [Related]

  • 14. [Immunosuppressive therapy of glomerulonephritis--controlled studies].
    Ferrari P, Frey FJ.
    Ther Umsch; 1993 Feb 15; 50(2):119-29. PubMed ID: 8456416
    [Abstract] [Full Text] [Related]

  • 15. [Current trends in the treatment of chronic glomerulonephritis].
    Belovezhdov N, Altŭnkova I, Neshev Kh, Robeva R, Gruev I.
    Vutr Boles; 1981 Feb 15; 20(5):54-64. PubMed ID: 7324454
    [Abstract] [Full Text] [Related]

  • 16. [Indications and limitations of immunosuppressive therapy in chronic glomerulonephritis].
    Ponticelli C, Brancaccio D, Locatelli F, Imbasciati E.
    Minerva Nefrol; 1969 Feb 15; 16(3):228-34. PubMed ID: 5356052
    [No Abstract] [Full Text] [Related]

  • 17. Longterm survival of lupus nephritis patients treated with azathioprine and prednisone.
    Barnett EV, Dornfeld L, Lee DB, Liebling MR.
    J Rheumatol; 1978 Feb 15; 5(3):275-87. PubMed ID: 372523
    [Abstract] [Full Text] [Related]

  • 18. [Therapeutic possibilities in chronic glomerulonephritis].
    Brass H.
    Munch Med Wochenschr; 1969 Aug 29; 111(35):1759-66. PubMed ID: 5820240
    [No Abstract] [Full Text] [Related]

  • 19. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
    Shen K, Yu Y, Tang Z, Liu Z, Li L.
    Chin Med J (Engl); 1997 Jul 29; 110(7):502-7. PubMed ID: 9594205
    [Abstract] [Full Text] [Related]

  • 20. The glomerular tip lesion: a steroid responsive nephrotic syndrome.
    Beaman M, Howie AJ, Hardwicke J, Michael J, Adu D.
    Clin Nephrol; 1987 May 29; 27(5):217-21. PubMed ID: 3594937
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.